DJG: Enzyme Immunoassay, Opiates
What it covers
An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.
The identification in 21 CFR 862.3650, opiate test system. FDA gives DJG no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252684 | Labcorp Fentanyl Urine Visual Test | Medtox Diagnostics, Inc. | Jan 29, 2026 | Traditional |
| K250741 | Evidence MultiSTAT DOA Urine MultiPlex | Randox Laboratories Limited | Jan 23, 2026 | Traditional |
| K253082 | LZI Buprenorphine II Enzyme Immunoassay | Lin-Zhi International, Inc. | Jan 16, 2026 | Traditional |
| K252520 | SEFRIA Hydrocodone Oral Fluid | Immunalysis Corporation | Sep 11, 2025 | Traditional |
| K251972 | Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen® Immunofluorescence Analyzer (OG-H180) | Healgen Scientific,, LLC | Aug 15, 2025 | Traditional |
| K251634 | LZI Fentanyl III Enzyme Immunoassay | Lin-Zhi International, Inc. | Jun 18, 2025 | Special |
| K240124 | BioSieve Fentanyl FIA Test Kit; BioSieve ToxiSmart FIA Reader | Vivachek Biotech (Hangzhou) Co., Ltd. | Jun 14, 2024 | Traditional |
| K240698 | Dochek® Multi-Drug Urine Test Dipcard Rx; Dochek® Multi-Drug Urine Test Dipcard | Guangzhou Decheng Biotechnology Co., Ltd. | May 10, 2024 | Traditional |
| K231904 | Rapid Fentanyl (FYL) Test Strip, Rapid Fentanyl (FYL) Test Dipcard | Co-Innovation Biotech Co., Ltd. | Mar 8, 2024 | Traditional |
| K232228 | Multi-drug Urine Test Cup, Multi-drug Urine Test Dip Card, Accurature Multi-drug Urine Test Cup, Accurature Multi-drug Urine Test Dip Card | Shanghai Accurature Diagnostics Co., Ltd. | Feb 23, 2024 | Traditional |
Clearances by year
82 DJG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 157 |
| 2025 | 3 | 31 |
| 2024 | 5 | 150 |
| 2023 | 10 | 140 |
| 2022 | 2 | 433 |
| 2021 | 3 | 422 |
| 2020 | 5 | 30 |
| 2019 | 3 | 235 |
| 2018 | 5 | 134 |
| 2017 | 4 | 101 |
| 2016 | 2 | 178 |
| 2015 | 12 | 141 |
| 2014 | 9 | 62 |
| 2013 | 5 | 60 |
| 2012 | 5 | 95 |
| 2011 | 6 | 233 |
Who submits
32 applicants cleared a DJG device since 2011. 77% of the clearances went to applicants in United States, then China (18%) and United Kingdom (5%). By type: Traditional 95% and Special 5%.
| Applicant | Clearances since 2011 |
|---|---|
| Lin-Zhi International, Inc. | 11 |
| Immunalysis Corporation | 8 |
| Guangzhou Wondfo Biotech Co., Ltd. | 7 |
| Microgenics Corporation | 6 |
| Ark Diagnostics, Inc. | 4 |
| Chemtron Biotech, Inc. | 4 |
| Randox Laboratories Limited | 4 |
| Siemens Healthcare Diagnostics, Inc. | 4 |
How FDA classifies it
Class II (special controls). An opiate test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.
From 21 CFR 862.3650. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.3650 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DJG clearances declared.
Ask about DJG
Questions about DJG
What is FDA product code DJG?
Product code DJG, “Enzyme Immunoassay, Opiates” in FDA's classification database, is a Class II device type under 21 CFR 862.3650 (opiate test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 215 clearances under DJG, 82 of them since 2011.
How many 510(k) clearances are there under DJG?
FDA’s 510(k) database listed 215 clearances under DJG as of Oct 29, 2026, 82 of them decided since 2011; the most recent decision was Jan 29, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DJG 510(k)?
For the 6 DJG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 83 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DJG clearances?
Since 2011: Lin-Zhi International, Inc. (11), Immunalysis Corporation (8), Guangzhou Wondfo Biotech Co., Ltd. (7), Microgenics Corporation (6) and Ark Diagnostics, Inc. (4). 32 applicants have cleared a DJG device in that time.